Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > 7-METHYLINDOLE-3-CARBOXALDEHYDE

7-METHYLINDOLE-3-CARBOXALDEHYDE

7-METHYLINDOLE-3-CARBOXALDEHYDE structure

7-METHYLINDOLE-3-CARBOXALDEHYDE 

structure
  • CAS No:

    4771-50-0

  • Formula:

    C10H9NO

  • Chemical Name:

    7-METHYLINDOLE-3-CARBOXALDEHYDE

  • Synonyms:

    3-FORMYL-7-METHYLINDOLE;7-METHYLINDOLE-3-ALDEHYDE;7-Methyl-3-carboxaldehyde;7-METHYLINDOLE-3-CARBOXALDEHYDE;7-Methyl-3-indolecarboxaldehyde;7-METHYLINDOLE-3-CARBOXYALDEHYDE;7-METHYL-1H-INDOLE-3-CARBALDEHYDE;7-Methylindole-3-carboxaldehyde98%;7-Methyl-1H-indole-3-carboxaldehyde;7-METHYLINDOLE-3-CARBOXALDEHYDE(7MeIAld)

  • Categories:

    Active Pharmaceutical Ingredients  >  Other Chemical Drugs

7-METHYLINDOLE-3-CARBOXALDEHYDE Basic Attributes

159.18

159.068420

91539

DTXSID20293694

2933990090

Characteristics

32.9

1.9

Pale yellow crystalline powder

1.2±0.1 g/cm3

206-208°C

341°C at 760 mmHg

168.0±29.8 °C

1.699

-20ºC

Safety Information

NONH for all modes of transport

3

R36/37/38

S26-S36

Xi

7-METHYLINDOLE-3-CARBOXALDEHYDE Use and Manufacturing

Methods of Manufacturing

General procedure: A 50 mL round bottom flask equipped with a magnetic stirring bar was charged with substituted indole 1 (1.0 mmol, 1.0 equiv), HMTA (2.0 mmol, 0.2803 g, 2.0 equiv), activated carbon (0.1 g) and DMF (2 mL). Then IGeneral procedure: A method for synthesizing compound III-1 wherein R1, R2 and R3 are simultaneously hydrogen in the formula III, the method comprising the steps of:(1) Add to a 50 mL round bottom flask1.0mmol indole(In the formula I, R1, R2, and R3 are both hydrogen) and1.0 mmol (0.140 g) of hexamethylenetetramine, then 2 mL of N, N-dimethylformamide (DMF), stirred in a magnetic stirrer to dissolve the solid, followed by the addition of 0.05 mmol (0.012 g) of crystalline trichloride Aluminum, connected to a reflux condenser, heated at 120 ° C, the reaction progress was monitored by TLC, and the reaction was cooled to room temperature after 1 h to prepare a suspension;(2) The suspension prepared in the step (1) is suction filtered with a funnel padded with diatomaceous earth.The filter cake was washed well with ethyl acetate, suction filtered, and the above operation was repeated until the filtrate had no product, and all the filtrates were combined.Dilute with 15 mL of saturated saline solution, disperse and separate the layers, and the aqueous layer was further extracted with ethyl acetate three times.Each time 10 mL, the ethyl acetate layer was combined and washed with 10 mL of 2 mol/L diluted hydrochloric acid.Wash with 10 mL of saturated sodium bicarbonate solution, and finally wash with 10 mL of saturated brine.The washed ethyl acetate layer was dried over anhydrous sodium sulfate, and after drying, the desiccant was filtered off.Then use a rotary evaporator to recover the solvent to concentrate the product, and finally, The residue is subjected to silica gel column chromatography using a mixture of n-hexane-ethyl acetate (V/V = 2:1) as an eluent to obtain a purified product.The mass of the compound III-indole-3-carbaldehyde is 0.137g, The product yield was 94percent.General procedure: A 50 mL round-bottomed flask equipped with a magnetic stirringbar was charged with the appropriate indole 1 (0.5 mmol, 1.0 equiv), 37percent aq HCHO (0.5 mmol, 0.0406 g, 1.0 equiv), 25percent aqNH3 (1.0 mmol, 0.0681 g, 2.0 equiv), FeCl3 (0.01 mmol, 0.0016 g, 2 molpercent), and DMF (2 mL). The flask was fitted with a reflux condenser, and the mixture was stirred at 130 °C under open air.When the reaction was complete (TLC), the mixture was cooledto r.t., diluted with sat. aq NaCl (10 mL) and 0.5 M aq HCl (2 mL), and extracted with EtOAc (3 x 7 mL). The organic layers werecombined, washed with sat. aq NaHCO3 (10 mL) and sat. aq NaCl(10 mL), dried (Na2SO4), and concentrated under reduced pressure.The residue was purified by flash column chromatography(silica gel, hexane–EtOAc).

Uses

Reactant for preparation of:• ;Tryptophan dioxygenase inhibitors pyridyl-ethenyl-indoles as potential anticancer immunomodulators1• ;Antibacterial and antituberculosis agents2• ;Antiandrogens effective against androgen receptor mutants3• ;Anti-bovine viral diarrhea virus (BVDV) agents4• ;Receptor subtype 5 antagonists5• ;Glucocorticoid receptor ligands6• ;Necroptosis inhibitors7• ;Orally efficacious small-molecule sctivator of the insulin receptor8

Computed Properties

Molecular Weight:159.18
XLogP3:1.9
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:1
Exact Mass:159.068413911
Monoisotopic Mass:159.068413911
Topological Polar Surface Area:32.9
Heavy Atom Count:12
Complexity:181
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.